| Period Ending | Jun 29, 2013 | Mar 30, 2013 | Dec 29, 2012 | Sep 29, 2012 |
|---|
|
Total Revenue
|
1,161,000
|
1,088,000
|
1,155,000
|
1,269,000
| | Cost of Revenue | 702,000 | 643,000 | 977,000 | 877,000 | | |
Gross Profit
|
459,000
|
445,000
|
178,000
|
392,000
| |
|
Operating Expenses |
|
Research Development | 308,000 | 312,000 | 313,000 | 328,000 |
|
Selling General and Administrative | 171,000 | 179,000 | 193,000 | 188,000 |
|
Non Recurring | 5,000 | 47,000 | 89,000 | 3,000 |
|
Others | 4,000 | 5,000 | 5,000 | 4,000 |
|
|
|
Total Operating Expenses | 488,000 | 543,000 | 600,000 | 523,000 | | | |
Operating Income or Loss
|
(29,000)
|
(98,000)
|
(422,000)
|
(131,000)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
| (2,000) | (2,000) | 18,000 |
|
Earnings Before Interest And Taxes | (29,000) | (100,000) | (424,000) | (113,000) |
|
Interest Expense | 42,000 | 44,000 | 45,000 | 44,000 |
|
Income Before Tax | (71,000) | (144,000) | (469,000) | (157,000) |
|
Income Tax Expense | 3,000 | 2,000 | 4,000 |
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (74,000) | (146,000) | (473,000) | (157,000) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(74,000)
|
(146,000)
|
(473,000)
|
(157,000)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(74,000)
|
(146,000)
|
(473,000)
|
(157,000)
|
|
0.02 (0.52%) 8:04AM EDT - Nasdaq Real Time Price